Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Receives $4.00 Average Target Price from Analysts

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) has been given a consensus rating of “Hold” by the four research firms that are currently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, two have given a hold rating and one has given a buy rating to the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $4.00.

BIOX has been the topic of several recent analyst reports. Wall Street Zen cut Bioceres Crop Solutions from a “hold” rating to a “sell” rating in a report on Saturday, April 4th. Weiss Ratings cut Bioceres Crop Solutions from a “sell (d)” rating to a “sell (d-)” rating in a report on Wednesday, May 6th.

Bioceres Crop Solutions Trading Down 4.9%

NASDAQ:BIOX opened at $0.41 on Friday. Bioceres Crop Solutions has a fifty-two week low of $0.35 and a fifty-two week high of $5.18. The company has a debt-to-equity ratio of 0.57, a current ratio of 0.88 and a quick ratio of 0.70. The stock has a market capitalization of $26.17 million, a PE ratio of -0.11 and a beta of 0.39. The business’s 50-day simple moving average is $0.49 and its 200-day simple moving average is $0.95.

Bioceres Crop Solutions (NASDAQ:BIOX) last released its quarterly earnings data on Monday, May 11th. The company reported ($0.16) earnings per share for the quarter, missing the consensus estimate of ($0.05) by ($0.11). Bioceres Crop Solutions had a negative net margin of 92.85% and a negative return on equity of 33.97%. The business had revenue of $39.40 million for the quarter, compared to the consensus estimate of $54.50 million. Sell-side analysts expect that Bioceres Crop Solutions will post -0.16 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Bioceres Crop Solutions

Several institutional investors have recently bought and sold shares of the company. Bank of America Corp DE lifted its stake in Bioceres Crop Solutions by 186.8% in the 4th quarter. Bank of America Corp DE now owns 5,735 shares of the company’s stock valued at $35,000 after acquiring an additional 3,735 shares in the last quarter. Jones Financial Companies Lllp lifted its stake in Bioceres Crop Solutions by 3,535.8% in the 1st quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company’s stock valued at $25,000 after acquiring an additional 5,339 shares in the last quarter. PDT Partners LLC lifted its stake in Bioceres Crop Solutions by 58.9% in the 2nd quarter. PDT Partners LLC now owns 28,180 shares of the company’s stock valued at $126,000 after acquiring an additional 10,449 shares in the last quarter. Virtu Financial LLC bought a new stake in Bioceres Crop Solutions in the 3rd quarter valued at approximately $40,000. Finally, Invesco Ltd. bought a new stake in Bioceres Crop Solutions in the 4th quarter valued at approximately $45,000. Institutional investors own 17.68% of the company’s stock.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.

Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.